T-cell engagers

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

UCB enters TCE space with $1.1B deal for autoimmune candidate

UCB has entered the red-hot T-cell engager space by paying $80 million for the rights to a Chinese biotech’s preclinical autoimmune candidate.
James Waldron Mar 4, 2026 8:20am
two arrows pointing different directions

Candid scores Nasdaq listing via reverse merger Rallybio

Mar 2, 2026 11:45am
weigh scale goliath outweigh balance bigger smaller even

BioNTech’s B7-H3 ADC hits ph. 3 at half the size of Merck’s

Feb 27, 2026 10:31pm
Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Astellas says 'I do' to Vir's T-cell engager in $1.7B deal

Feb 23, 2026 5:00pm
BMS

BMS pens $850M tumor pact with T-cell engager biotech Janux

Jan 22, 2026 8:35am
Three blocks displaying from left to right a person a handshake and another person

InduPro nabs 2nd Big Pharma deal with $950M Lilly pact

Jan 7, 2026 3:52pm